Sarkar, S., Swiercz, R., Kantara, C., Hajjar, K. A., and Singh, P. (2011). Annexin
A2 mediates up-regulation of NF-κB, β-catenin, and stem cell in response to
progastrin in mice and HEK-293 cells. Gastroenterology 140, 583–595.
Senbanjo, L. T., and Chellaiah, M. A. (2017). CD44: a multifunctional cell surface
adhesion receptor is a regulator of progression and metastasis of cancer Cells.
Front. Cell. Dev. Biol. 5:18. doi: 10.3389/fcell.2017.00018
Suwannakul, N., Ma, N., Thanan, R., Pinlaor, S., Ungarreevittaya, P., Midorikawa,
K., et al. (2018). Overexpression of CD44 variant 9: a novel cancer stem cell
marker in human cholangiocarcinoma in relation to inflammation. Mediators
Inflam. 2018, 4867234–4867241.
Taniguchi, D., Saeki, H., Nakashima, Y., Kudou, K., Nakanishi, R., Kubo, N., et al.
(2018). CD44v9 is associated with epithelial-mesenchymal transition and poor
outcomes in esophageal squamous cell carcinoma. Cancer Med. 7, 6258–6268.
doi: 10.1002/cam4.1874
Thanee, M., Loilome, W., Techasen, A., Sugihara, E., Okazaki, S., Abe, S.,
et al. (2016). CD44 variant-dependent redox status regulation in liver flukeassociated cholangiocarcinoma: a target for cholangiocarcinoma treatment.
Cancer Sci. 107, 991–1000. doi: 10.1111/cas.12967
Vaquero, J., Guedj, N., Clapéron, A., Nguyen Ho-Bouldoires, T. H., Paradis, V., and
Fouassier, L. (2017). Epithelial-mesenchymal transition in cholangiocarcinoma:
from clinical evidence to regulatory networks. J. Hepatol. 66, 424–441. doi:
10.1016/j.jhep.2016.09.010
Wada, F., Koga, H., Akiba, J., Niizeki, T., Iwamoto, H., Ikezono, Y., et al.
(2018). High expression of CD44v9 and xCT in chemoresistant hepatocellular
carcinoma: potential targets by sulfasalazine. Cancer Sci. 109, 2801–2810. doi:
10.1111/cas.13728
Wada, T., Ishimoto, T., Seishima, R., Tsuchihashi, K., Yoshikawa, M., Oshima,
H., et al. (2013). Functional role of CD44v-xCT system in the development
of spasmolytic polypeptide-expressing metaplasia. Cancer Sci. 104, 1323–1329.
doi: 10.1111/cas.12236
Wang, S.-S., Jiang, J., Liang, X.-H., and Tang, Y.-L. (2015). Links between cancer
stem cells and epithelial-mesenchymal transition. Onco Targets Ther. 8, 2973–
2980.
Wang, Y., and Zhou, B. P. (2013). Epithelial-mesenchymal transition—a hallmark
of breast cancer metastasis. Cancer Hallm. 1, 38–49. doi: 10.1166/ch.2013.1004
Wei, C.-Y., Zhu, M.-X., Yang, Y.-W., Zhang, P.-F., Yang, X., Peng, R., et al.
(2019). Downregulation of RNF128 activates Wnt/β-catenin signaling to induce
cellular EMT and stemness via CD44 and CTTN ubiquitination in melanoma.
J. Hematol. Oncol. 12:21.
Xue, J., Zhu, Y., Sun, Z., Ji, R., Zhang, X., Xu, W., et al. (2015). Tumorigenic
hybrids between mesenchymal stem cells and gastric cancer cells enhanced
cancer proliferation, migration and stemness. BMC Cancer 15:793. doi: 10.1186/
s12885-015-1780-1
Yasui, W., Kudo, Y., Naka, K., Fujimoto, J., Ue, T., Yokozaki, H., et al. (1998).
Expression of CD44 containing variant exon 9 (CD44v9) in gastric adenomas
and adenocarcinomas: relation to the proliferation and progression. Int. J.
Oncol. 12, 1253–1258.
Zhang, K., Guo, Y., Wang, X., Zhao, H., Ji, Z., Cheng, C., et al. (2017). WNT/betacatenin directs self-renewal symmetric cell division of hTERT(high) prostate
cancer stem cells. Cancer Res. 77, 2534–2547. doi: 10.1158/0008-5472.can-161887
Zhang, K., Li, B., Li, P., Yang, X., Cui, H., and Liu, X. (2019). Cell-based
immunofluorescence assay for screening the neurogenesis potential of new
drugs in adult hippocampal neural progenitor cells. Acta Neurobiol. Exp. 79,
302–308.
Auvinen, P., Tammi, R., Parkkinen, J., Tammi, M., Agren, U., Johansson, R., et al.
(2000). Hyaluronan in peritumoral stroma and malignant cells associates with
breast cancer spreading and predicts survival. Am. J. Pathol. 156, 529–536.
doi: 10.1016/s0002-9440(10)64757-8
Avnet, S., and Cortini, M. (2016). Role of pericellular matrix in the regulation of
cancer stemness. Stem Cell Rev. 12, 464–475. doi: 10.1007/s12015-016-9660-x
Barat, S., Chen, X., Cuong Bui, K., Bozko, P., Götze, J., Christgen, M., et al. (2017).
Gamma-Secretase Inhibitor IX (GSI) impairs concomitant activation of Notch
and Wnt-beta-catenin pathways in CD44+ gastric cancer stem cells. Stem Cells
Transl. Med. 6, 819–829. doi: 10.1002/sctm.16-0335
Evanko, S. P., Potter-Perigo, S., Petty, L. J., Workman, G. A., and Wight, T. N.
(2015). Hyaluronan controls the deposition of fibronectin and collagen and
modulates TGF-β1 induction of lung myofibroblasts. Matrix Biol. 42, 74–92.
doi: 10.1016/j.matbio.2014.12.001
Golshani, R., Lopez, L., Estrella, V., Kramer, M., Iida, N., and Lokeshwar, V. B.
(2008). Hyaluronic acid synthase-1 expression regulates bladder cancer growth,
invasion, and angiogenesis through CD44. Cancer Res. 68, 483. doi: 10.1158/
0008-5472.can-07-2140
Griess, B., Tom, E., Domann, F., and Teoh-Fitzgerald, M. (2017). Extracellular
superoxide dismutase and its role in cancer. Free Radic. Biol. Med. 112, 464–479.
doi: 10.1016/j.freeradbiomed.2017.08.013
Guo, W., Chen, W., Yu, W., Huang, W., and Deng, W. (2013). Small interfering
RNA-based molecular therapy of cancers. Chin. J. Cancer 32, 488–493. doi:
10.5732/cjc.012.10280
Jiang, R., Niu, X., Huang, Y., and Wang, X. (2016). β-Catenin is important
for cancer stem cell generation and tumorigenic activity in nasopharyngeal
carcinoma. Acta Biochim. Biophys. Sin. 48, 229–237. doi: 10.1093/abbs/gmv134
Kiuchi, S., Ikeshita, S., Miyatake, Y., and Kasahara, M. (2015). Pancreatic cancer
cells express CD44 variant 9 and multidrug resistance protein 1 during mitosis.
Exp. Mol. Pathol. 98, 41–46. doi: 10.1016/j.yexmp.2014.12.001
Lamouille, S., Xu, J., and Derynck, R. (2014). Molecular mechanisms of epithelialmesenchymal transition. Nat. Rev. Mol. Cell. Biol. 15, 178–196. doi: 10.1038/
nrm3758
Li, Y., Lin, K., Yang, Z., Han, N., Quan, X., Guo, X., et al. (2017). Bladder
cancer stem cells: clonal origin and therapeutic perspectives. Oncotarget 8,
66668–66679. doi: 10.18632/oncotarget.19112
Long, A., Giroux, V., Whelan, K. A., Hamilton, K. E., Tétreault, M.-P., Tanaka,
K., et al. (2015). WNT10A promotes an invasive and self-renewing phenotype
in esophageal squamous cell carcinoma. Carcinogenesis 36, 598–606. doi: 10.
1093/carcin/bgv025
Lu, X., Gao, J., Zhang, Y., Zhao, T., Cai, H., and Zhang, T. (2018). CTEN induces
epithelial-mesenchymal transition (EMT) and metastasis in non small cell lung
cancer cells. PLoS One 13:e0198823. doi: 10.1371/journal.pone.0198823
Miwa, T., Nagata, T., Kojima, H., Sekine, S., and Okumura, T. (2017). Isoform
switch of CD44 induces different chemotactic and tumorigenic ability in
gallbladder cancer. Int. J. Oncol. 51, 771–780. doi: 10.3892/ijo.2017.4063
Miyoshi, S., Tsugawa, H., Matsuzaki, J., Hirata, K., Mori, H., Saya, H., et al. (2018).
Inhibiting xCT improves 5-Fluorouracil resistance of gastric cancer induced
by CD44 variant 9 expression. Anticancer Res. 38, 6163–6170. doi: 10.21873/
anticanres.12969
Montgomery, N., Hill, A., McFarlane, S., Neisen, J., O’Grady, A., Conlon, S.,
et al. (2012). CD44 enhances invasion of basal-like breast cancer cells by
upregulating serine protease and collagen-degrading enzymatic expression and
activity. Breast Cancer Res. 14:R84.
Ogihara, K., Kikuchi, E., Okazaki, S., Hagiwara, M., Takeda, T., Matsumoto,
K., et al. (2019). Sulfasalazine could modulate the CD44v9-xCT system and
enhance cisplatin-induced cytotoxic effects in metastatic bladder cancer. Cancer
Sci. 110, 1431–1441. doi: 10.1111/cas.13960
Oh, Y.-K., and Park, T. G. (2009). siRNA delivery systems for cancer treatment.
Adv. Drug Deliv. Rev. 61, 850–862. doi: 10.1016/j.addr.2009.04.018
Phi, L. T. H., Sari, I. N., Yang, Y.-G., Lee, S.-H., Jun, N., Kim, K. S., et al. (2018).
Cancer stem cells (CSCs) in drug resistance and their therapeutic implications
in cancer treatment. Stem Cells Int. 2018, 5416923–5416938.
Prochazka, L., Tesarik, R., and Turanek, J. (2014). Regulation of alternative splicing
of CD44 in cancer. Cell Signal. 26, 2234–2239. doi: 10.1016/j.cellsig.2014.07.011
Frontiers in Cell and Developmental Biology | www.frontiersin.org
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 Suwannakul, Ma, Midorikawa, Oikawa, Kobayashi, He,
Kawanishi and Murata. This is an open-access article distributed under the terms
of the Creative Commons Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the original author(s) and the
copyright owner(s) are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
15
June 2020 | Volume 8 | Article 417
...